Loading...
Loading...
Citigroup reiterated Magellan Health Services
MGLN at Buy with a $58 price target.
Citigroup noted, "On Monday, Magellan announced the loss of its contract with Horizon Blue Cross Blue Shield in New Jersey — We estimate this contract will generate $193 million in revenue in 2012, and assuming an average segment margin, around $30 million in EBITDA, or $0.65 per share. The current contract doesn't end until December 31, 2013, so Magellan's earnings won't be pressured until 2014. … EBITDA growth in 2014 is still possible, but it will require both the retention of the Maricopa business and a meaningful new contract win."
Magellan Health Services closed at $49.79 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in